The Latest Breaking News from European Commission

The European Commission (EC) has granted conditional marketing authorization (CMA) to BioMarin Pharmaceutical’s (NASDAQ:BMRN) lead asset ROCTAVIAN (valoctocogene roxaparvovec) gene therapy for the treatment of severe hemophilia A (congenital Factor VIII deficiency) in adult patients. BioMarin shares traded as high as 2.28 percent, in a range of $91.39 to $93.68…

On February 24, Russia launched a full-scale assault on Ukraine. These are the main events of the war over six months.

The EU tax haven and ‘dirty money’ blacklists discriminate against Caribbean countries and other poor nations while letting western nations off the hook

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

The European Commission said on Wednesday it had "taken note" of Britain's announcement that it had launched dispute resolution proceedings with the EU to gain post-Brexit access to the bloc's scientific research programmes.

Britain has launched dispute resolution proceedings with the European Union to try to gain access to the bloc's scientific research programmes, including Horizon Europe, the government said on Tuesday, in the latest post-Brexit row.

The EU has updated those planning to visit Italy, Spain, France and Greece on the launch date for a scheme that will see UK passport holders pay a charge to enter the country.

The system will be "mandatory" for people travelling to any one of 26 places including Spain, France, Greece and Italy

This comes as no surprise. Every time there has been a proposal to revamp the credit, it has left people, groups, parties, companies, and even countries upset.